Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
212M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
556K
-
Shares change
-
+362K
-
Total reported value, excl. options
-
$374K
-
Value change
-
+$244K
-
Number of buys
-
3
-
Number of sells
-
-1
-
Price
-
$0.67
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q3 2025
6 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q3 2025.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 556K shares
of 212M outstanding shares and own 0.26% of the company stock.
Largest 6 shareholders include SANDERS MORRIS HARRIS LLC (303K shares), LUMINUS MANAGEMENT LLC (250K shares), BROWN, LISLE/CUMMINGS, INC. (1.53K shares), Rise Advisors, LLC (853 shares), AdvisorNet Financial, Inc (206 shares), and Family Legacy Financial Solutions, LLC (0 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.